Text size :

Drugs, Aceti (Salutequità): “Continuous and integrated update of therapies and tests is needed”

ADNKRONOS

November 12, 2026

Rome, Nov 12. (Adnkronos Health) – “The system for updating Essential Levels of Assistance is too slow, bureaucratic, and rigid: the last update arrived after nine years and cannot keep up with the evolution of people’s needs, technologies, and the epidemiological framework.” Tonino Aceti, president of Salutequità, stated this, speaking at the event ‘Essential Levels of Assistance and Next Generation Sequencing, The challenge of innovation between updating and access’, organized by Salutequità in Rome. “The problem – he added – is particularly evident in precision medicine: AIFA can authorize and reimburse innovative drugs, including in oncology and for rare diseases, while the genetic tests needed to identify patients who can benefit from them follow a distinct path and arrive later. Thus, there is a risk of having the drug, but not the test to access it”.

“It is necessary that decisions on the reimbursement of drugs and tests proceed concurrently, through an integrated and dynamic mechanism. The issue, while the Budget Law is being discussed, cannot be postponed, otherwise personalized therapies become an opportunity for a few and concrete possibilities for treatment are lost,” concluded the president of Salutequità.

Jiji Press

Related

Page TOP